Evidence map›Paper›PMID 29424488›Full record

ArticleJournal of cellular and molecular medicine2018

Lipopolysaccharide enhances TGF-β1 signalling pathway and rat pancreatic fibrosis.

Li Sun, Ming Xiu, Shuhua Wang, David R Brigstock, Hongyan Li, Limei Qu, Runping Gao

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 61 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Li SunDepartment of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.
Ming XiuDepartment of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.
Shuhua WangDepartment of Surgical Gastroenterology, First Hospital of Jilin University, Changchun, China.
David R BrigstockThe Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Hongyan LiDepartment of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.
Limei QuDepartment of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.
Runping GaoDepartment of Hepatic Biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.ORCID 0000-0001-7148-6173
Jilin University · CNNationwide Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic stellate cells (PSCs) play a critical role in fibrogenesis during alcoholic chronic pancreatitis (ACP). Transforming growth factor-beta1 (TGF-β1) is a key regulator of extracellular matrix production and PSC activation. Endotoxin lipopolysaccharide (LPS) has been recognized as a trigger factor in the pathogenesis of ACP. This study aimed to investigate the mechanisms by which LPS modulates TGF-β1 signalling and pancreatic fibrosis. Sprague-Dawley rats fed with a Lieber-DeCarli alcohol (ALC) liquid diet for 10 weeks with or without LPS challenge during the last 3 weeks. In vitro studies were performed using rat macrophages (Mφs) and PSCs (RP-2 cell line). The results showed that repeated LPS challenge resulted in significantly more collagen production and PSC activation compared to rats fed with ALC alone. LPS administration caused overexpression of pancreatic TLR4 or TGF-β1 which was paralleled by an increased number of TLR4-positive or TGF-β1-positive Mφs or PSCs in ALC-fed rats. In vitro, TLR4 or TGF-β1 production in Mφs or RP-2 cells was up-regulated by LPS. LPS alone or in combination with TGF-β1 significantly increased type I collagen and α-SMA production and Smad2 and 3 phosphorylation in serum-starved RP-2 cells. TGF-β pseudoreceptor BAMBI production was repressed by LPS, which was antagonized by Si-TLR4 RNA or by inhibitors of MyD88/NF-kB. Additionally, knockdown of Bambi with Si-Bambi RNA significantly increased TGF-β1 signalling in RP-2 cells. These findings indicate that LPS increases TGF-β1 production through paracrine and autocrine mechanisms and that LPS enhances TGF-β1 signalling in PSCs by repressing BAMBI via TLR4/MyD88/NF-kB activation.

Indexed as

AlcoholsAnimalsCollagenFibrosisGene Expression RegulationHumansLipopolysaccharidesMacrophagesMembrane ProteinsMyeloid Differentiation Factor 88PancreasPancreatic Stellate CellsPancreatitis, AlcoholicRatsSignal TransductionSmad2 ProteinAlcoholsBambi protein, ratCollagenLipopolysaccharidesMembrane ProteinsMyd88 protein, ratMyeloid Differentiation Factor 88Smad2 ProteinSmad2 protein, ratTgfb1 protein, ratTlr4 protein, ratToll-Like Receptor 4Transforming Growth Factor beta1alcohollipopolysaccharidepancreatic fibrosispancreatic stellate cellTGF-β1

Identifiers

PMID29424488
PMCPMC5867168
OpenAlexW2789957233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.